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In vitro fertilization is considered from multiple ethical positions and whether or not 
it is limited to disease prevention or used for genetic enhancement. The first can be 
in line with most ethical theories provided time and resources are allowed for the 
technology to be provided for all. The latter seems to devalue humans and remove 
compassion for the disenfranchised. 
 
 In vitro fertilization (IVF) in humans 
was first accomplished in 1978.1 IVF is the 
fertilization of a female egg by a male sperm 
cell outside of the uterus.  The woman is 
first given medication that stimulates the 
production of multiple eggs during her next 
cycle. Once the eggs are ready for ovulation, 
they are removed via a minor surgical 
procedure and combined with sperm 
obtained from a male to form a zygote. The 
zygote is allowed to grow for roughly two to 
three days in vitro. The resulting embryo is 
then placed inside the female’s uterus for 
implantation and maturation. 
 IVF is used worldwide to enable 
women who are naturally infertile to 
conceive; it is also used to prevent undesired 
genetic traits or characteristics in one’s 
offspring. This paper addresses IVF’s 
validity and role in the future of human 
reproduction and ultimately evolution from 
three major ethical perspectives including 
Deontology, Utilitarianism and Virtue 
Ethics as well as my own perspective based 




 IVF has been a viable procedure for 
three decades. Like any medical intervention 
IVF provides unprecedented options already 
and will do so even more in the near future. 
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One advancement with IVF is Pre-
Implantation Genetic Diagnosis (PGD). 
PGD is possible because of the 3 to 5 day 
window between oocyte fertilization and 
embryo implantation. This gap allows PGD, 
which is a procedure where one cell is 
removed from an approximately eight cell in 
vitro embryo and tested to identify that 
embryo’s genetic makeup to prevent specific 
genetic defects.2 Such genetic defects 
include monogenic and X-chromosome 
linked diseases as well as other 
chromosomal abnormalities including cystic 
fibrosis, Alzheimer’s and even pre-
disposition to cancer.3 
 Technology such as IVF provides 
groundbreaking genetic therapy but is 
controversial because of its potential 
powers. Parents can use IVF and PGD to 
guarantee they will have a child free of 
painful, fatal, and devastating genetic 
disease. Potentially doctors could use PGD 
and other procedures with it to change the 
genetic code of an embryo to prevent heart 
failure and blindness. This is the powerful 
promise that IVF is providing. 
 
Disadvantages  
     There is the potential, however, to go 
beyond merely having a child free of genetic 
anomalies. Genetic Enhancement is possible 
too. Instead of using IVF to eliminate 
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devastating diseases such as Huntington’s, 
parents may wish to enhance mere 
appearance or attractiveness (e.g. eliminate 
genetic links for baldness or obesity). 
Theoretically, the technology could be 
available to make sure one’s child is smarter 
or more physically capable than another. 
 This potentially unlimited control 
over reproductive abilities, and essentially 
the future genetics of humanity, raises 
ethical questions regarding who will have 
this ability, how will it be monitored, what is 
the nature and purpose of such control when 
it is used, and what kind of impact will it 
have on society.  
 
Various Ethical Approaches 
 One way to evaluate the ethics of 
IVF is to examine it through the three most 
prominent ethical approaches. We will 
consider Deontological, Utilitarian, and 
Virtue ethic approaches. 
 Kantian Deontology 
 This ethical theory relies on what 
Kant called the categorical imperative 
which insists that one should act in such a 
way that one’s actions should become a 
universal law.4 This idea is somewhat 
comparable to the Golden Rule often taught 
to young children, “treat others the way you 
would have them treat you.”  The 
categorical imperative also requires that an 
individual to never treat others as simply a 
means but also as an end in themselves.5 
The basis of this ethical approach is rooted 
in respect for others over everything else. 
Kant believes that every person is due an 
inherent respect and dignity based on their 
existence as human beings. It is worth 
noting that Kant essentially applies respect 
to the most basic and universal human 
quality - existing as a human. Applications 
of categorical imperatives require one to act 
in such a way that he or she treats humanity, 
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whether in his or her own person or in the 
person of any other, never merely as a 
means to an end, but always at the same 
time as an end. 
 Deontology, specifically Kant’s 
translation of his categorical imperatives 
into perfect and imperfect duties, seems at 
odds with the actions and effects of IVF. 
The effects of the action on the person who 
receives it are in full compliance with 
Kant’s duties if said action impacts only 
those individuals and not others. However, 
because of the extension of morality beyond 
those directly affected by an act, a 
deontologist would decide against the use of 
IVF. Genetic therapy, altering genes to 
correct defects that inhibit relatively normal 
function, is good for the person whose 
parents had the financial means to prevent 
the disability. But if being born ‘normal’ is 
deemed an unalienable right, then humans 
born with what is considered abnormal are 
in jeopardy. 
 Advancements made on the backs of 
those with defects to create a world where 
they are undesirable uses people as a means 
to an end. IVF, even if it is limited to genetic 
therapy, diminishes the perceived value of 
those who are unable to directly benefit 
from the therapy. 
 Utilitarian Ethics 
 When considering Utilitarian ethics 
there are two major veins of thought: Act-
Utilitarianism and Rule-Utilitarianism.6 I 
will only consider the former. Act-
Utilitarianism (from here on, referenced 
only as Utilitarianism) follows the 
underlying principle that an individual 
should act in a way that will produce the 
greatest amount of good for the greatest 
amount of people. This theory differs from 
deontology in that it does not depend on the 
specific morality of an act in itself for 
justification but on the consequence of that 
6 ibid. 
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act on society as a whole. In this way 
Utilitarianism can be considered 
circumstantial ethical reasoning.7 For 
instance, where Kant would say that lying to 
someone is morally wrong every time 
because it disrespects that individual, a 
utilitarian will believe that lying is justified 
as long as it maximizes the total happiness 
of everyone affected in that situation. 
 This mode of thinking allows the 
Utilitarian to ultimately take a not now but 
later stance on IVF. Based on a recent study 
by Cohen and Chen the average cost of each 
cycle of IVF in the United States is $12,400 
with the average cost of IVF resulting in a 
live birth falling between $66,667 and 
$114,286.8 While IVF is not illegal or 
regulated, it is certainly not a viable option 
for everyone at that price considering that 
less than one in five insurance companies 
cover the procedure.9 Such a high cost 
implies that only the wealthy can afford IVF 
furthering the chasm between the rich and 
the poor. There is no doubt that IVF may 
greatly enhance the happiness of those who 
can afford it but that includes only a few 
wealthy couples. 
 Another concern of utilitarian 
tension related to IVF is the effect it might 
have on illnesses still affecting those who 
are without the means to be born genetically 
healthy. For this reason, a utilitarian 
perspective cannot endorse an immediate 
implementation of genetic therapy and/or 
enhancement. If the privileged few are able 
to make themselves immune to the 
consequences, their funding may diminish at 
a greater rate than the majority of the 
world’s need for treatment of those diseases 
from which they are unable to afford genetic 
prevention. 
 The history of medicine in the world 
has proven this to be a valid concern for the 
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utilitarian that it may happen again. In the 
United States, Tuberculosis, a bacterial 
infection, poses no threat to one’s life or 
happiness because antibiotics have been 
developed to treat it. So, for the most part, 
research to continue to fight Tuberculosis 
has stopped despite the fact that it continues 
to kill millions of people every year 
worldwide because that is mostly in 
developing countries where the money and 
power is limited. Thus, any medical 
intervention including IVF only has the 
ability to maximize happiness for all of 
society once it is available to all. Until then 
the resources would have a greater utility 
elsewhere. 
 Virtue Ethics 
 Virtue Ethics is in many ways a 
system of moral preparedness. It instills 
virtues or traits of character that ready one to 
act in the most moral way in any given 
circumstance. Within this system, the why 
always takes precedence over the what.10 
Following that line of logic, the disparity 
between the rich and poor is not a matter of 
means but rather of motive. For example, 
current cancer treatments are costly and 
available to those who can afford them. Why 
do people of means give millions of dollars 
to cancer research centers that benefit the 
general population when they could hire 
private researchers and physicians? Virtue 
Ethics would attribute this generosity to 
empathy. Consequently, virtue-based 
ideology focuses on nurturing a desire to do 
great good. Virtue Ethics’ seeming 
indifference to IVF and genetic engineering 
may have something to do with its 
paramount emphasis on a quality believed to 
be developed, not born with – virtue.11 
 One particular virtue that is at the 
center of new dilemmas is what Aristotle 
referred to as phronesis – the virtue of 
10 Bright, 2013 
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understanding context and circumstance. 
The underlying notion of Virtue Ethics is 
that one must prepare oneself to decide what 
is right when the situation calls for it as 
opposed to learning what is right and moral 
beforehand and hoping those rules are 
eternally applicable.  
 IVF, like many areas of medical 
science, has moved far beyond its origins.  
It provides the opportunity to have a child 
and the ability to heal or enhance that new 
being before it is born. Genetic therapy and 
genetic enhancement, though rooted in the 
same technology, come with different sets of 
desires and outcomes. Altering genetic 
makeup to ease suffering and prevent 
disease may be a wonderful achievement in 
history if it is given the time and resources 
to reach the masses and provide positive, 
sustainable change for all. 
 When considering the ethical 
implications of genetic modification, one 
would do well to consider the purpose of 
ethics in general. Ethics provides structure 
for those who wish to deal justly with their 
neighbor, to generate welfare beyond 
themselves. If genetic therapy brings unity 
and equality to humankind, it may be one of 
the most ethical pursuits of all time. Genetic 
enhancement, on the other hand, is a 
different thing entirely, finding its roots 
deep in self-aggrandizement far removed 
from enhancing community welfare. 
 As technology evolves so must 
definitions of basic human rights. With the 
ability to do more comes the debate over 
how much more we have the right to do, 
what should we do, and what we will do. 
Human actions, interactions, and 
achievements now more than ever have 
global consequences. Progress of every kind 
moves faster and the discussion of the right 
to try has morphed into the right to succeed. 
 But at what point does the right to 
succeed grow so monstrous that one dictates 
the very fabric of another’s being on one’s 
own terms? If one person’s ideal world 
includes all of Germany being blonde haired 
and blue eyed, is it their right to bring about 
that world? If it is one’s right to succeed at 
running a large plantation, can they breed 
only the strong to work on it? Do scientific 
advancements warrant the dictation of every 
gene in a human being? A child is a separate 
organism from its parents. It is a human, a 
person, a son or daughter. When genetics are 
something to be engineered and perfected, 
new life is no longer created, only an 
iteration of an old life. Parents will no 
longer raise a child, but their ideal version of 
a child. If IVF is allowed to be used for 
genetic enhancement, there will be a society 
where diversity is devalued and only 
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